# Trade Mark Journal No.2026/034 21 August 2026

## WO0000001931518 (5)

Office of origin: United States of America

Date of International Registration:14 July 2026
Date of designation in the UK: 14 July 2026

International priority date claimed: 28 January 2026 (United States of America) (99620401)

Class 5
  Pharmaceutical preparations for the treatment of central nervous system (CNS) disorders.

Diaxis Therapeutics LLC

Representative: Michael R. Graif Brown Rudnick LLP, 7 Times Square, New York NY 10036, UNITED STATES OF AMERICA